Piper Sandler Maintains Overweight on CG Oncology, Raises Price Target to $70
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Kelsey Goodwin maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $55 to $70.
Piper Sandler analyst Kelsey Goodwin maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $55 to $70.